Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Supportive Care

20 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Basic Science

    Breast

    VICCBRE1445

    04/21/2014

    Optical Imaging of Breast Tumors

    Diagnostic

    Miscellaneous

    VICCSAR1458

    04/22/2015

    F18-FES PET/CT Imaging of Desmoid Tumors

    Health Services Research

    Retinoblastoma (Pediatrics)

    VICCREACH1447

    04/16/2014

    Retinoblastoma Survivor Study (RBSS)

    Other

    Breast - Female

    VICC090513-M

    01/25/2012

    Arthralgia in women with early stage breast cancer taking aromatase inhibitors: the Breast Cancer Adjuvant Therapy (BCAT) longitudinal cohort/registry study

    Other

    Breast

    ECOGBREE2Z04-M

    06/11/2008

    Quality of LIfe in Younger Breast Cancer Survivors

    Supportive Care

    Neuro-Oncology

    NRGNEUCC001

    07/14/2016

    A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy with or without Hippocampal Avoidance in Patients with Brain Metastases

    Supportive Care

    Pediatric Leukemia
    Pediatric Lymphoma
    Pediatric Supportive Care

    COGACCL1333

    04/28/2016

    A Phase III Randomized, Open Label, Multi-center Study on the Safety and Efficacy of Apixaban for Thromboembolism Prevention versus No Systemic Anticoagulant Prophylaxis during Induction Chemotherapy in Children with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) or Lymphoma (T or B cell) Treated with Pegylated (PEG) L-Asparaginase

    Supportive Care

    Head/Neck

    VICCSUPP1529

    06/08/2015

    Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients

    Supportive Care

    Breast

    VICCBRE1438

    06/19/2014

    A Randomized Trial Evaluating Bioimpedance Spectroscopy versus Tape Measurement in the Prevention of Lymphedema following Locoregional Treatment for Breast Cancer

    Supportive Care

    Pediatric Supportive Care

    VICCPED1389

    12/12/2013

    Canines and Childhood Cancer (CCC) Full Trial

    Supportive Care

    Breast - Female

    ALLIANCEA221102-M

    11/06/2012

    Randomized study of subQ testosterone in the adjuvant treatment of postmenopausal women with aromatase inhibitor induced arthralgias

    Treatment

    Adrenocortical
    Lung
    Sarcoma
    Wilms / Other Kidney (Pediatrics)

    COGADVL1522

    08/02/2016

    A Phase 2 Study of IMGN901 (Lorvotuzumab Mertansine; IND# 126953, NSC# 783609) in Children with Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor (MPNST) and Synovial Sarcoma

    Treatment

    Leukemia

    VICCHEM1597

    02/17/2016

    A Phase 3 Open-label, Multicenter, Randomized Study of ASP2215 versus Salvage Chemotherapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) with FLT3 Mutation

    Treatment

    Bladder

    VICCURO15139

    02/01/2016

    Observation Versus Immediate Surgery for Low Risk Bladder Cancer

    Treatment

    Multiple Myeloma

    VICCHEM15112

    01/11/2016

    A Phase 1/2 Open-label Study of the Safety, Tolerability and Efficacy of the Selective Inhibitor of Nuclear Export (SINE) Compound KPT-8602 in Patients with Relapsed/Refractory Multiple Myeloma

    Treatment

    Lymphoma

    VICCHEM14125

    11/13/2015

    A Phase 1-2 Multi-Center Study Evaluating the Safety and Efficacy of KTE-C19 in Subjects with Refractory Aggressive Non-Hodgkin Lymphoma (NHL)

    Treatment

    Bladder
    Urologic

    ECOGUROEA8141

    08/27/2015

    A Prospective Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery for Patients with High Grade Upper Tract Urothelial Carcinoma

    Treatment

    Leukemia
    Lymphoma
    Pediatric Leukemia
    Pediatric Lymphoma

    COGAALL1231

    05/13/2015

    A Phase III Randomized Trial Investigating Bortezomib NSC# 681239; IND# 58443) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)

    Treatment

    Lung
    Non Small Cell

    VICCTHO1443

    03/11/2015

    A Phase III, Randomized, Open-Label, Cross-Over, Multi-Center, Safety and Efficacy Study to Evaluate Nab-Paclitaxel (Abraxane?) as Maintenance Treatment after Induction with Nab-Paclitaxel Plus Carboplatin in Subjects with Squamous Cell Non-Small Cell Lung Cancer (NSCLC)

    Treatment

    Neuroblastoma (Pediatrics)

    COGANBL1232

    08/20/2014

    Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma


    Print this page for your doctor